Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Dry eye syndromes | D015352 | — | H04.12 | — | — | — | 1 | 2 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | 1 | 3 | 1 | — | 8 | 12 |
Inflammation | D007249 | MP_0001845 | — | 2 | 3 | 1 | — | 7 | 12 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | 3 | 3 | — | 6 | 10 |
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | 2 | 1 | — | 7 | 9 |
Syndrome | D013577 | — | — | 1 | 3 | 2 | — | 5 | 9 |
Hypercholesterolemia | D006937 | — | — | 1 | 4 | 3 | — | 2 | 8 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | — | 1 | 1 | — | 6 | 7 |
Hypertension | D006973 | EFO_0000537 | I10 | — | 2 | 1 | — | 5 | 7 |
Overweight | D050177 | — | E66.3 | 1 | 1 | 1 | — | 5 | 7 |
Breast neoplasms | D001943 | EFO_0003869 | C50 | — | 2 | 1 | — | 2 | 5 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | — | 15 | 16 |
Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | 1 | 1 | — | — | 2 | 4 |
Oxidative stress | D018384 | EFO_1001905 | — | 2 | 2 | — | — | 1 | 4 |
Morbid obesity | D009767 | EFO_0001074 | — | — | 1 | — | — | 1 | 2 |
Pain | D010146 | EFO_0003843 | R52 | 1 | 2 | — | — | — | 2 |
Aging | D000375 | GO_0007568 | R41.81 | 1 | 2 | — | — | — | 2 |
Prostatic neoplasms | D011471 | — | C61 | — | 1 | — | — | 1 | 2 |
Fibrosis | D005355 | — | — | 1 | 1 | — | — | — | 2 |
Cystic fibrosis | D003550 | EFO_0000390 | E84 | 1 | 1 | — | — | — | 2 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | 1 | — | — | 1 | 2 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 2 | — | — | — | 6 | 8 |
Hyperglycemia | D006943 | — | R73.9 | 1 | — | — | — | 1 | 2 |
Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | — | — | — | — | 1 |
Fallopian tube neoplasms | D005185 | — | — | 1 | — | — | — | — | 1 |
Ovarian epithelial carcinoma | D000077216 | — | — | 1 | — | — | — | — | 1 |
Non-small-cell lung carcinoma | D002289 | — | — | 1 | — | — | — | — | 1 |
Radiation effects | D011830 | — | — | 1 | — | — | — | — | 1 |
Poisoning | D011041 | EFO_0008546 | T65.91 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | — | — | — | 6 | 6 |
Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | — | — | 5 | 5 |
Healthy diet | D000072001 | — | — | — | — | — | — | 4 | 4 |
Hyperlipidemias | D006949 | EFO_0003774 | E78.5 | — | — | — | — | 3 | 3 |
Prediabetic state | D011236 | EFO_1001121 | R73.03 | — | — | — | — | 3 | 3 |
Lipid metabolism disorders | D052439 | — | — | — | — | — | — | 3 | 3 |
Hypertriglyceridemia | D015228 | EFO_0004211 | — | — | — | — | — | 2 | 2 |
Keratoconjunctivitis sicca | D007638 | EFO_1000906 | — | — | — | — | — | 2 | 2 |
Coronary disease | D003327 | — | — | — | — | — | — | 2 | 2 |
Coronary artery disease | D003324 | — | I25.1 | — | — | — | — | 2 | 2 |
Drug common name | — |
INN | — |
Description | — |
Classification | Unknown |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | — |
PDB | — |
CAS-ID | — |
RxCUI | — |
ChEMBL ID | — |
ChEBI ID | — |
PubChem CID | — |
DrugBank | — |
UNII ID | — |